SCHEMBL7686867

SCHEMBL7686867

Cc1ccc2c(Cl)cc(S(=O)(=O)NCCSc3ccccc3)c(O)c2n1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.46
ALDH1A1 P00352 9/20 0.44
KMT2A Q03164 4/20 0.43
MEN1 O00255 2/20 0.43
TSHR P16473 2/20 0.42
HSD17B10 Q99714 1/20 0.42
GAA P10253 2/20 0.41
KDM4E B2RXH2 5/20 0.39
HTT P42858 4/20 0.39
PKM P14618 1/20 0.39
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NPC1 O15118 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
LMNA P02545 1/20 0.36
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7686853 0.85 MEN1 (0.39) MAPTALDH1A1KMT2AMEN1TSHR
SCHEMBL7686849 0.85 MEN1 (0.39) MAPTALDH1A1KMT2AMEN1TSHR
SCHEMBL8311550 0.84 MAPT (0.49) MAPTALDH1A1GAAHTTNPSR1
SCHEMBL7685938 0.84 MAPT (0.46) MAPTALDH1A1KMT2AMEN1GAA
SCHEMBL7691423 0.82 TDP1 (0.50) MAPTALDH1A1KMT2AMEN1GAA
SCHEMBL7689285 0.82 MAPT (0.51) MAPTALDH1A1GAAKDM4EHTT
SCHEMBL7686834 0.82 ALDH1A1 (0.52) MAPTALDH1A1KMT2AMEN1GAA
SCHEMBL7692710 0.80 NPC1 (0.55) MAPTALDH1A1GAAKDM4EHTT
SCHEMBL7691430 0.79 KMT2A (0.50) MAPTALDH1A1KMT2AMEN1TSHR
SCHEMBL7686086 0.79 KDM4E (0.57) MAPTKDM4ERAB9ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6211376-B1 HERPES VIRUS, CYTOMEGALO VIRUS, VARICELLA-ZOSTER VIRUS,EPSTEIN-BARR VIRUS PHARMACIA & UPJOHN COMPANY 2001-04-03 US claimed
EP-0927164-A1 8-HYDROXY-7-SUBSTITUTED QUINOLINES AS ANTI-VIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 1999-07-07 EP claimed
WO-1998011073-A1 8-HYDROXY-7-SUBSTITUTED QUINOLINES AS ANTI-VIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 1998-03-19 WO claimed
US-6500842-B1 N-((4-CHLOROPHENYL)METHYL)-8-HYDROXY-7-QUINOLINECARBOXAMIDE ADMINISTERED AS VIRICIDES AGAINST HERPES VIRUS PHARMACIA & UPJOHN COMPANY 2002-12-31 US disclosed
US-6310211-B1 ANTI-VIRAL ACTIVITY AGAINST HERPES VIRUS, CYTOMEGALOVIRUS. MANY OF THESE COMPOUNDS ARE ALSO ACTIVE AGAINST VARICELLA ZOSTER VIRUS, EPSTEIN-BARR VIRUS, HERPES SIMPLEX VIRUS AND HUMAN HERPES VIRUS TYPE 8 PHARMACIA & UPJOHN COMPANY 2001-10-30 US disclosed
US-6252080-B1 HERPES, CYTOMEGALO VIRUS PHARMACIA & UPJOHN COMPANY 2001-06-26 US disclosed
US-6211376-B1 HERPES VIRUS, CYTOMEGALO VIRUS, VARICELLA-ZOSTER VIRUS,EPSTEIN-BARR VIRUS PHARMACIA & UPJOHN COMPANY 2001-04-03 US disclosed
EP-0927164-A1 8-HYDROXY-7-SUBSTITUTED QUINOLINES AS ANTI-VIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 1999-07-07 EP disclosed
WO-1998011073-A1 8-HYDROXY-7-SUBSTITUTED QUINOLINES AS ANTI-VIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 1998-03-19 WO disclosed